Catalyst Wire Dossier Catalyst Wire Dossier

OTX-DED

dexamethasone · Ocular Therapeutix, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OTX-DED, covering 2023-02-22 to 2024-07-10. Get the full timeline:

Most recent: Clinical Trial Update: OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED) [Phase 2]

See pricing